Dear colleague,

Your participation is requested in an e-Delphi survey study to identify the most important outcome measures to assess the impacts of infection prevention and control (IPC) interventions for prevention of transmission of multi-drug resistant gram-negative bacteria (MDRGNB).

Transmission of MDRGNB to patients in healthcare facilities is a major threat to healthcare. IPC is a scientific approach and practical solution designed to prevent harm caused by infection to patients and health workers. We believe you may want to contribute to this study because of your involvement in the research or care of patients requiring IPC interventions.

This study is being conducted as part of a Healthcare Infection Society grant. The results will be used to support a national strategy around prevention of transmission of MDRGNB.

The participant information sheet in the link below provides you with a more detailed overview of the research and what this study involves. Each survey should not take any more than 20 minutes to complete and there will be 3 surveys spaced out of a period of several months.

Please follow the link below to  the participant information sheet and consent for the study: 
https://leeds.onlinesurveys.ac.uk/the-costrans-mdrgnb-study-registration-and-consent

If you have any questions, please do not hesitate to contact the research team at the University of Leeds: 
​​​​​​​
Dr Razan Saman, Registrar in Infectious Diseases and Microbiology
E: umrsa@leeds.ac.uk

Dr Andrew Kirby, Associate Professor and Microbiology Consultant
E: a.kirby@leeds.ac.uk  

We look forward to hearing from you and hope you can contribute your expertise to this important part of the study. 

Kind Regards

Dr Razan Saman MBChB MRCP DTM&H
HIS Graham Ayliffe Training Fellow

St James’s University Hospital